Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of hypereosinophilia in university health care systems.
Li JC, Kahwash B, Ganju A, Ogbogu PU, Mathur SK. Li JC, et al. Among authors: mathur sk. Ann Allergy Asthma Immunol. 2021 Mar;126(3):295-297. doi: 10.1016/j.anai.2020.11.019. Epub 2020 Dec 2. Ann Allergy Asthma Immunol. 2021. PMID: 33276118 No abstract available.
Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults.
Olson AA, Evans MD, Johansson MW, Kim CH, Manthei DM, Gaumnitz EA, Mathur SK. Olson AA, et al. Among authors: mathur sk. Ann Allergy Asthma Immunol. 2016 Oct;117(4):387-393.e2. doi: 10.1016/j.anai.2016.08.008. Epub 2016 Aug 31. Ann Allergy Asthma Immunol. 2016. PMID: 27590636 Free PMC article.
Variability of blood eosinophil count as an asthma biomarker.
Mathur SK, Fichtinger PS, Evans MD, Schwantes EA, Jarjour NN. Mathur SK, et al. Ann Allergy Asthma Immunol. 2016 Nov;117(5):551-553. doi: 10.1016/j.anai.2016.08.010. Epub 2016 Aug 31. Ann Allergy Asthma Immunol. 2016. PMID: 27590639 Free PMC article. No abstract available.
Real-world dosing of omalizumab for chronic spontaneous urticaria.
McIntyre AP, Viswanathan RK, Moss MH, Mathur SK. McIntyre AP, et al. Among authors: mathur sk. Ann Allergy Asthma Immunol. 2020 Feb;124(2):211-212. doi: 10.1016/j.anai.2019.11.028. Epub 2019 Dec 2. Ann Allergy Asthma Immunol. 2020. PMID: 31805358 No abstract available.
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen MM, Roufosse F, Wang SA, Verstovsek S, Durrani SR, Rothenberg ME, Pongdee T, Butterfield J, Lax T, Wechsler ME, Stein ML, Ogbogu PU, Kahwash BM, Mathur SK, Simon D, Akuthota P, Holland N, Wetzler L, Ware JM, Guo C, Fay MP, Khoury P, Klion AD, Bochner BS. Chen MM, et al. Among authors: mathur sk. J Allergy Clin Immunol Pract. 2022 May;10(5):1217-1228.e3. doi: 10.1016/j.jaip.2022.02.006. Epub 2022 Feb 15. J Allergy Clin Immunol Pract. 2022. PMID: 35181548 Free PMC article.
Omalizumab for treatment of idiopathic angioedema.
Goswamy VP, Lee KE, McKernan EM, Fichtinger PS, Mathur SK, Viswanathan RK. Goswamy VP, et al. Among authors: mathur sk. Ann Allergy Asthma Immunol. 2022 Nov;129(5):605-611.e1. doi: 10.1016/j.anai.2022.07.017. Epub 2022 Jul 30. Ann Allergy Asthma Immunol. 2022. PMID: 35914662 Clinical Trial.
Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
Khoury P, Roufosse F, Kuang FL, Ackerman SJ, Akuthota P, Bochner BS, Johansson MW, Mathur SK, Ogbogu PU, Spencer LA, Wechsler ME, Zimmermann N, Klion AD; International Eosinophil Society Clinical Research Interest Group. Khoury P, et al. Among authors: mathur sk. J Leukoc Biol. 2024 Mar 8:qiae051. doi: 10.1093/jleuko/qiae051. Online ahead of print. J Leukoc Biol. 2024. PMID: 38457125
276 results